LinearDNA telomerase reverse transcriptase vaccine

LinearDNA telomerase reverse transcriptase vaccine is an investigational **DNA cancer vaccine** built on Applied DNA Sciences' PCR-produced LinearDNA platform and encoding **telomerase reverse transcriptase**, a broadly expressed tumor-associated antigen. The vaccine was designed to induce antigen-specific cellular immune responses against **TERT-expressing tumor cells**, functioning as an **anticancer immunotherapy** rather than by directly inhibiting telomerase enzymatic activity. Preclinical reports from Applied DNA Sciences and EvviVax described immunogenicity and antitumor activity in mouse models, and the TERT construct was licensed for **veterinary applications**, particularly development toward **canine B-cell lymphoma**. The available public information identifies it as a platform-derived linear DNA amplicon vaccine candidate and does not indicate marketing approval.

Other names

LinearDNA TERT vaccinelinDNA TERT vaccineanti-telomerase reverse transcriptase cancer vaccineTERT DNA vaccine